Tempest Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Tempest Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2011 to Q3 2024.
  • Tempest Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$10.6M, a 60.1% decline year-over-year.
  • Tempest Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$35.6M, a 16.5% decline year-over-year.
  • Tempest Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$29.2M, a 15.8% increase from 2022.
  • Tempest Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$34.6M, a 28.4% decline from 2021.
  • Tempest Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$27M, a 39.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$35.6M -$10.6M -$3.96M -60.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$31.7M -$9.58M -$2.11M -28.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$29.6M -$7.97M -$393K -5.18% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$29.2M -$7.51M +$1.42M +15.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 -$30.6M -$6.59M +$2.18M +24.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$32.8M -$7.47M +$1.3M +14.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$34.1M -$7.58M +$580K +7.11% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$34.6M -$8.93M -$1.6M -21.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$33M -$8.77M -$1.04M -13.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$32M -$8.77M -$1.99M -29.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$30M -$8.16M -$3.03M -59.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$27M -$7.34M +$21K +0.29% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$27M -$7.74M -$13.2M -242% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$13.8M -$6.79M -$1.55M -29.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$12.3M -$5.13M +$7.01M +57.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$19.3M -$7.36M +$5.47M +42.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$24.8M $5.43M +$17.2M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$42M -$5.24M +$4.92M +48.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$46.9M -$12.1M -$1.48M -13.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$45.4M -$12.8M -$3.14M -32.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-29
Q3 2019 -$42.3M -$11.8M -$3.95M -50.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$38.3M -$10.2M -$5.17M -104% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$33.1M -$10.7M -$6.27M -143% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$26.9M -$9.69M +$32.7M +77.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-11
Q3 2018 -$59.6M -$7.81M +$1.6M +17% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$61.2M -$4.99M +$12.9M +72.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 -$74.1M -$4.39M +$10.2M +69.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$84.3M -$42.4M -$20M -89.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$64.3M -$9.41M +$9.56M +50.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$73.8M -$17.9M +$311K +1.71% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$74.2M -$14.6M +$6.85M +32% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 -$81M -$22.4M -$2.13M -10.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$78.9M -$19M -$1.19M -6.71% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$77.7M -$18.2M -$1.07M -6.21% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$76.6M -$21.4M -$4.63M -27.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$72M -$20.2M -$1.95M -10.7% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-15
Q3 2015 -$70M -$17.8M -$5.37M -43.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$64.7M -$17.2M -$7.58M -79% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$57.1M -$16.8M -$9.16M -120% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$47.9M -$18.3M -$7.28M -66.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-02
Q3 2014 -$40.7M -$12.4M -$5.47M -79% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$35.2M -$9.6M -$3.57M -59.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$31.6M -$7.65M -$2.48M -47.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$29.1M -$11M -$6.8M -162% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 -$22.3M -$6.93M -$3.81M -122% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$18.5M -$6.02M -$2.79M -86.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$15.7M -$5.18M -$2.21M -74.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$13.5M -$4.21M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 -$3.12M -$2.35M -303% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 -$3.23M -$2.82M -689% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
Q1 2012 -$2.97M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 -$774K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$410K Apr 6, 2011 Jun 30, 2011 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.